AstraZeneca PLC (LSE:AZN) has become the first UK-listed company to surpass a £200 billion stock market valuation after shares gained on Tuesday.
Shares ticked up 1.2% to 12,928p throughout the day, leaving the pharmaceutical giant with a £200.02 billion valuation.
This comes after shares have climbed almost 20% this year, with the company surpassing oil heavyweight Shell PLC (LSE:SHEL, NYSE:SHEL) in April to become the most valuable London-listed company.